Maryland

Judge: Md. can act against drug price-gouging, for now

ANNAPOLIS, Md. - (AP) - An effort by drug makers to block Maryland's first-in-the-nation law against pharmaceutical price gouging was denied by a federal judge on Friday.

A group representing makers of generic prescription drugs sought to stop the law from taking effect this Sunday, calling it an "unconstitutional overreach" that will create market instability.

U.S. District Judge Marvin Garbis denied the request by the Association for Accessible Medicines for an injunction as a lawsuit proceeds. He is allowing litigation to proceed on the association's contention that the law is vague, but dismissed its other arguments.

Garbis wrote that the association has not persuaded him that the law "is substantially likely to be held unconstitutional."

"Moreover, the court finds that an erroneous grant of a preliminary injunction would cause substantial harm by permitting the sale of essential drugs to Maryland residents at unconscionable prices," Garbis wrote.


More Stories in the News